Group: Team

Kara Seifert

Kara Seifert serves as Executive Administrator and Accounting Associate in the Finance Department. Her wide-ranging skill set was built through a variety of positions and opportunities. Kara has been an entrepreneur and a graduate research fellow at NASA’s Langley Research Center. She has been employed as a graphic artist and as a mathematical copy editor

Cody Kirk

My educational background consists of obtaining a Bachelor’s Degree and Master’s Degree from the Fisher School of Accounting at the University of Florida. Additionally, I obtained my Certified Public Accountant designation through the State of Florida. After my educational endeavors, I spent the next 8 years at PricewaterhouseCoopers in public accounting where I became an

Christina Lockhart

With over 18 years’ working in pharma, biotech, CROs, and research centers, Christina brings a wealth of experience including management and monitoring of Phase 1 through Phase 4 pharmaceutical, biologic, device, and tobacco studies. After leaving an orthopaedic research site, she has focused primarily on rare-disease and novel therapy study management. Christina has developed study

Travis Autrey

My educational background consists of obtaining a Bachelor’s Degree in accounting from the Fisher School of Accounting at the University of Florida as well as a Masters in Business Administration from Auburn University. Additionally, I obtained my Certified Public Accountant designation through the State of Florida. After my educational endeavors, I spent time in public

Bryan Hoang

Bryan has over 10 years of experience in developing transformative medicines for the treatment of chronic indications including oncology, CNS diseases and ophthalmology. Bryan completed his doctorate at the University of Toronto in Pharmaceutical Sciences and post-doctoral fellowships at the Ontario Institute for Cancer Research and STTARR Innovation Center. Prior to joining Aceragen, Bryan served

Carl Kraus

Carl is the Chief Medical Officer of Aceragen. He is an Infectious Disease physician with more than 20 years’ experience in drug development, ranging from discovery and first-in-man studies through late-phase/risk-management program implementation. He has been the Principal Investigator for multiple NIAID, NCI and DoD funded research programs and is also a former FDA Medical

Denise Watts

Ms. Watts is Senior Manager, Finance. She has been working in drug development for > 15 years across CROs and biotechnology companies. Ms. Watts has broad experience in supporting clinical trial programs as well as coordinating activities of Medical & Scientific Affairs teams. In these roles she provided administrative support and assured compliance with requisite

Noah Wolfson

Noah comes to Aceragen after having served a diverse set of roles in biotech, consulting, venture, and academia. Most recently Noah came from Molekule Consulting where he advised management of some of the top pharmaceutical companies on clinical trial and commercial strategy. Along with his strong subject matter expertise, Noah brings his experience leading diverse

Ray Reilly

With over 25 years in the research industry, Ray has extensive operational, business, and global clinical development experience. Ray’s roles have spanned the spectrum from gene modification bench science through to CRO and Biotech executive positions. Ray has delivered from FIH studies to pivotal studies leading to product approval. This range of experience enables him

Greg Spalla

Greg has almost 30 years of experience managing Supply Chain Organizations for Global Commercial Pharmaceutical and emerging Biotech Companies. In this past experience, he has had responsibility for distribution, sourcing, forecast planning, purchasing (Direct and Indirect) and worked on numerous commercial product launches of both NDA and ANDA products, as well as a rich pipeline